Musculoskeletal Diseases

438 trials 179 recruiting

Filter these 438 trials by phase, country and sponsor.

Open in Search →

Randomized multicenter double-blind controlled trial comparing anakinra to prednisone for gout flare in patients with chronic kidney disease… Ended

2024-514347-28-00 Men and women over 18 years of age with renal failure r 5 2022-06-02
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-center, Phase III Study to Evaluate the Efficacy and Safety of Baricit… Ended

2024-518556-22-00 polymyalgia rheumatica 5 2022-05-10
A phase 2, multicenter, randomized, double blind, active controlled, parallel group study assessing the analgesic effect and safety of two d… Ended

2024-513940-27-00 Chronic low back pain 4 2021-11-19
Study of efficacy, safety and tolerability of DFV890 in patients with knee osteoarthritis Ended

2023-507559-30-00 Knee Osteoarthritis 4 2021-11-09
A Study of Nusinersen Among Participants With Spinal Muscular Atrophy Who Received Onasemnogene Abeparvovec (RESPOND) Ended

2023-505640-18-00 Spinal Muscular Atrophy 6 2021-09-02
Study of efficacy, safety, and tolerability of LNA043 in patients with symptomatic knee osteoarthritis Ended

2023-509937-37-00 Osteoarthritis 4 2021-07-21
"A Phase 3 study of Viltolarsen in boys with Duchenne Muscular Dystrophy (DMD)" Ended

2023-507146-91-00 Duchenne Muscular Dystrophy (DMD) 5 2021-06-07
Assessment of Pain After Botulinum Toxin Injections in Osteoarthritis of the thumb Ended

2024-517280-23-00 Osteoarthritis of the first carpometacarpal joint 4 2021-04-01
The My-JIA trial Ended

2023-510118-21-00 Juvenile Idiopathic Arthritis 6 2020-12-01
Two-Part Study for Dose Determination of Vesleteplirsen (SRP-5051) (Part A), Then Dose Efficacy (Part B) in Participants With Duchenne Muscu… Ended

2023-509935-23-00 Duchenne Muscular Dystrophy 4 2020-08-21
Investigating the role of JAK inhibition in achieving and maintaining disease remission in psoriatic arthritis (PsA). Ended

2024-511401-40-00 Psoriatic Arthritis 6 2020-03-03
Long-term safety, tolerability, and efficacy of losmapimod treatment in subjects with FSHD Ended

2024-512732-30-00 Facioscapulohumeral Muscular Dystrophy 1 (FSHD1) 4 2019-12-06
Evaluation of Safety, Tolerability, and Changes in Biomarker and Clinical Outcome Assessments of Losmapimod for FSHD1 With Extension (FSHD) Ended

2024-512736-29-00 Facioscapulohumeral Muscular Dystrophy 1 (FSHD1) 4 2019-08-23
A multicentre clinical trial: Alveolar bone augmentation using MSCs and biphasic calcium phosphate granules prior to dental implants (Behand… Ended

2024-517976-39-00 Alveolar bone augmentation in patient with bone defects 10 2018-07-01
RCT part: COBRA-Slim with or without fast access to TNF blockade for remission induction in early RA. LTE part: Long Term observational fol… Ended

2023-510189-28-00 Rheumatoid Arthritis 6 2018-05-15
ABATACEPT VERSUS TOCILIZUMAB BY SUBCUTANEOUS ADMINISTRATION FOR THE TREATMENT OF RHEUMATOID ARTHRITIS IN TARGETED TREATMENT INADEQUATE RESPO… Ended

2024-515600-39-00 Adults patients suffering from rheumatoid arthritis and 6 2018-01-23
A Multicenter, Open-label, Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Subjects with Rheumatoid Arthritis Ended

2024-513919-27-00 Rheumatoid arthritis 5 2017-09-14
A research study of a new investigational medicinal product for the treatment of Duchenne Muscular Dystrophy patients Ended

2024-514698-23-00 Patients with Duchenne Muscular Dystrophy Amenable to E 5 2017-05-15
Effects of a single denosumab injection on reduction of total contact cast treatment and consolidation of bone fractures caused by acute Cha… Ended

2024-518637-28-00 Charcot, diabetes 5
A study to assess the safety, tolerability and pharmacokinetics of tideglusib in subjects with hepatic impairment compared to healthy subjec… Ended

2024-516774-30-00 Hepatic impairment 3
TOFA-PREDICT Ended

2024-510903-12-00 Psoriatic arthritis 6
A Randomized, Double-blind, Parallel-group, Active-controlled Study to Compare the Efficacy, Pharmacokinetics, Pharmacodynamics, Safety, and… Ended

2024-512417-41-00 Osteoporosis 5
A Phase 2a multi-center, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of Burfiralimab (hzVSF-v13)… Ended

2023-507944-35-00 rheumatoid arthritis 4
Phase 1/2 Study of AOC 1020 in Adults with Facioscapulohumeral Muscular Dystrophy (FSHD) Ended

2022-502096-32-00 Facioscapulohumeral muscular dystrophy (FSHD) 7